• Title/Summary/Keyword: MCF-7 세포

검색결과 332건 처리시간 0.022초

때죽나무의 부위별 면역 및 항암활성 비교 (Comparison of Immune modulatary and Anticancer Activities according to the Parts of the Styrax japonica Sieb. et Zucc.)

  • 권오웅;김철희;김효성;권민철;안주희;이학주;강하영;이현용
    • 한국약용작물학회지
    • /
    • 제15권3호
    • /
    • pp.170-176
    • /
    • 2007
  • B cell과 T cell을 이용한 면역세포의 생육 촉진 실험에서, B${\cdot}$T cell은 배양 6일째 수피 추출물이 각각 $4.2{\times}10^4$cells/ml, $5.0{\times}10^4$cells/ml로 가장 높은 세포농도를 나타냈다. 면역세포를 이용한 cytokine의 분비량 측정실험에서는 수피추출물이 배양 시간에 따른 cytokine의 분비가 가장 높게 나타나는 것을 확인할 수 있었다. 각 세포의 TNF-${\alpha}$의 분비량은 6일째 최고의 분비량을 나타내었고, 수피 추출물의 경우 대조군에 비해 7-8배 가량 더 높은 분비량을 나타낸 것을 확인하였다. IL-6의 경우 6일째 최고의 분비량을 나타내었고, 수피 추출물에서 가장 높은 분비량을 나타내었다. 또한 때죽나무 추출물을 첨가한 배지에 의한 NK cell의 면역활성을 측정하였으며, 모든 추출물에서 배양시간에 따라 유의적으로 증가하는 것을 확인하였다. 그 중 때죽나무 수피 추출물에서 B cell의 경우 $14.1{\times}10^4$cells/ml, T cell의 경우 $15.3{\times}10^4$cells/ml 으로 가장 높은 생육 활성을 나타내었다. 인간 정상 신장세포인 HEK293을 이용한 세포 독성을 살펴본 결과, 각 추출물은 1.0mg/ml의 농도에서 최고 27.4%의 세포독성을 나타내었다. 또한 항암활성 효과를 살펴보기 위하여 2가지의 암세포를 이용하였는데, AGS와 MCF-7에서 뿌리추출물의 경우 1.0mg/ml의 농도에서 65정도의 높은 억제활성을 나타내었고, 또한 암세포의 생육활성에 대한 정상 세포의 세포독성의 비로 나타낸 선택적 사멸도는 고농도에서는 모두 1.5이상으로 나타나 모두 암세포에 대한 선택성이 있는 것으로 나타났다. Bcl-2 단백질 정량을 통한 항암활성 실험에서는, IOD 값이 수피, 목부, 잎 순으로 각각 72, 186, 200의 결과를 나타내었다. 본 실험 결과를 통하여 때죽나무의 기능성 소재로서의 가능성을 엿볼 수 있었고, 유용성분 분리와 생리활성에 대한 연구가 보다 다각적으로 이루어져야 할 것으로 생각된다.

광곽향 메탄올 추출물의 항산화, 항염증 및 암세포 증식 억제 효과 (Anti-oxidant, Anti-inflammatory and Anti-cancer Effect of Methanol Extract of Pogostemon cablin)

  • 윤승근;진수정;정현영;윤희정;도미영;김병우;권현주
    • 생명과학회지
    • /
    • 제25권1호
    • /
    • pp.44-52
    • /
    • 2015
  • 본 연구에서는, 암세포 증식 억제효능과 항산화, 항염증 효능을 동시에 가지는물질을 탐색하였다. 그 결과, 광곽향 메탄올 추출물이 A549, HepG2, MCF7, HT29 등 다양한 암세포에 대하여 세포성장억제효과를 보였고, A549에 대해 특이적으로 뛰어난 사멸효과를 보였다. 광곽향 메탄올 추출물에 의한 A549에서의 항암 효과는 p38 - Cdc25A - Cdk - Cyclin - Rb pathway를 통해 G1 arrest 유도로 연결되는 것으로 사료된다. 또한 DPPH를 통한 free radical의 소거능 확인 결과 항산화 효과를 가지고 있는 것을 확인하였고, 대식세포(RAW 264.7)의 iNOS 발현을 감소시켜 LPS에 의해 유도되는 NO의 생성을 유의적으로 억제함을 확인했다. 이러한 결과들로부터 광곽향 메탄올 추출물이 항산화, 항염증, 항암 후보물질 소재로 활용가능 할 뿐 아니라, 다양한 건강기능성 소재로 활용가능할 것이라 사료된다.

NDRG2 Controls COX-2/PGE2-Mediated Breast Cancer Cell Migration and Invasion

  • Kim, Myung-Jin;Kim, Hak-Su;Lee, Soo-Hwan;Yang, Young;Lee, Myeong-Sok;Lim, Jong-Seok
    • Molecules and Cells
    • /
    • 제37권10호
    • /
    • pp.759-765
    • /
    • 2014
  • N-myc downstream-regulated gene 2 (NDRG2), which is known to have tumor suppressor functions, is frequently down-regulated in breast cancers and potentially involved in preventing the migration and invasion of malignant tumor cells. In the present study, we examined the inhibitory effects of NDRG2 overexpression, specifically focusing on the role of cyclooxygenase-2 (COX-2) in the migration of breast cancer cells. NDRG2 overexpression in MDA-MB-231 cells inhibited the expression of the COX-2 mRNA and protein, the transcriptional activity of COX-2, and prostaglandin $E_2$ ($PGE_2$) production, which were induced by a treatment with phorbol-12-myristate-13-acetate (PMA). Nuclear transcription factor-${\kappa}B$ (NF-${\kappa}B$) signaling attenuated by NDRG2 expression resulted in a decrease in PMA-induced COX-2 expression. Interestingly, the inhibition of COX-2 strongly suppressed PMA-stimulated migration and invasion in MDA-MB-231-NDRG2 cells. Moreover, siRNA-mediated knockdown of NDRG2 in MCF7 cells increased the COX-2 mRNA and protein expression levels and the PMA-induced COX-2 expression levels. Consistent with these results, the migration and invasion of MCF7 cells treated with NDRG2 siRNA were significantly enhanced following treatment with PMA. Taken together, our data show that the inhibition of NF-${\kappa}B$ signaling by NDRG2 expression is able to suppress cell migration and invasion through the down-regulation of COX-2 expression.

부정항암탕(扶正抗癌湯)의 사람 췌장암 세포주 PANC-1에 대한 항종양(抗腫瘍) 효과(效果) (Anti-cancer Effects of Bujeonghangamtang on Human Pancreatic Cancer Cell Line PANC-1)

  • 김훈;원진희;문구
    • 대한한의학방제학회지
    • /
    • 제15권1호
    • /
    • pp.213-228
    • /
    • 2007
  • Objectives : The purpose of this report was to investigate the chemotherapeutic effect of Bujeonghangamtang against cancer cells. Materials and Methods : Various cancer cell lines including PANC-1, C6 glioma, SH-SY5Y, HepG2, and MCF-7 cells, were used. Apoptosis was determined by DAPI nuclei staining and flow cytometry in PANC-1 cells treated with 1 mg/ml Bujeonghangamtang for 48 hr. Expression of cell cycle arrest mediators including, cdc2p34 and cyclin B1 proteins were measured by Western blot analysis. Mitochondrial membrane potential was measured by fluorescence staining with JC-1, rhodamine 123. Result : Bujeonghangamtang induced the apoptosis of PANC-1, which was characterized as nucleic acid and genomic DNA fragmentation, chromatin condensation, and sub-G0/G1 fraction of cell cycle increase. but not C6 glioma, SH-SY5Y, HepG2, and MCF-7 cells. PANC-1 cells were markedly sensitive to Bujeonghangamtang. Treatment with Bujeonghangamtang resulted in the decreased expression of cdc2p34 and cyclin B1. Treatment with Bujeonghangamtang also increased the ROS production and induced mitochondrial dysfunction. Conclusion : Bujeonghangamtang exerted cytotoxicity against human Pancreatic cancer cells via cell cycle arrest-mediated apoptotic signaling including ROS production and mitochondrial dysfunction. Our data suggest that Bujeonghangamtang may be an important modulator of chemosensitivity of cancer cells against anticancer chemotherapeutic agents.

  • PDF

아가리쿠스 버섯 균사체 추출물 및 분획물의 항돌연변이원성 및 세포 독성 효과 (The Antimutagenic Effects and Cytotoxic Activities of Agaricus blazei Murill Mycelium Extracts and Fractions)

  • 오현택;김수현;유수정;함승시
    • 동아시아식생활학회지
    • /
    • 제17권4호
    • /
    • pp.563-570
    • /
    • 2007
  • This study was performed to observe the antioxidative effects, antimutagenic capacity, and cytotoxic activity of the 70% ethanol extract, and fractions, of Agaricus blazei Murill mycelium, using DPPH free radical scavenging ability, the Ames test, and SRB assay, respectively. Among the fractions, ethyl acetate showed the most effective antioxidative capacity according to the $RC_{50}$(73.6 $\mu$g/mL) of the scavenging effect on the DPPH radical. The inhibition rate of both the aqueous fraction and 70% ethanol extract(200 $\mu$g/plate) toward the Salmonella typhimurium TA100 strain was 94.6%, and it was 89.4% against the mutagenesis induced by MNNG(0.4 $\mu$g/plate). In addition, an identical concentration of the 70% ethanol extract in the TA98 strain, and the ethyl acetate fraction in the TA100 strain, showed inhibition rates of 80.3% and 76.9%, respectively, the highest activities against the mutagenesis induced by 4NQO(0.15 $\mu$g/plate). The cytotoxic effects of the 70% ethanol extract and its fractions increased with increasing sample concentration against human cervical adenocarcinoma(HeLa), human hepatocellular carcinoma(Hep3B), human breast adenocarcinoma(MCF-7), human stomach adenocarcinoma(AGS), and human lung carcinoma (A549). A 1 mg/mL concentration of the ethyl acetate fraction showed cytotoxicities of 77%, 83.8%, 82.1%, 83.1%, and 92.6% against HeLa, Hep3B, MCF-7, AGS and A549, respectively.

  • PDF

저근백피 추출물이 유선암 세포에서의 신생혈관 미치는 영향 (Effects on Inhibition of Angiogenesis in MCF-7 Cells by the Aqueous Root Extract of Ailanthus Altissima)

  • 정지학;윤용갑;전병훈;박혜련;안원근
    • 동의생리병리학회지
    • /
    • 제18권6호
    • /
    • pp.1613-1616
    • /
    • 2004
  • The cellular response to hypoxia is controlled to a large degree by the transcription factor Hypoxia-inducible factor-1(HIF-1). HIF-1 is a transcription factor that is activated by hypoxia and plays a critical role in the development of the cancer phenotype. HIF-1 regulates transcription of a number of genes crucial for tumor survival under hypoxic conditions, including vascular endothelial growth factor(VEGF), erythropoietin(Epo) and several glycolytic enzymes. Tumors in which hypoxia can not induce HIF-1 transcriptional activity remain small and fail to metastasize. In this study, we examined whether aqueous root extract of Ailanthus altissima (REA) downregulate HIF-1, VEGF and p53, and raise the possibility that depletion of these proteins and the anti proliferative activities of REA have any effects on inhibition of angiogenesis in MCF-7 cells. Pharmacologic targeting of specific signal transduction pathways related to oncogenic transformation is a promising approach in cancer treatment. Therefore, REA could be a candidate drug for further clinical development.

Tectoridin, a Poor Ligand of Estrogen Receptor α, Exerts Its Estrogenic Effects via an ERK-Dependent Pathway

  • Kang, Kyungsu;Lee, Saet Byoul;Jung, Sang Hoon;Cha, Kwang Hyun;Park, Woo Dong;Sohn, Young Chang;Nho, Chu Won
    • Molecules and Cells
    • /
    • 제27권3호
    • /
    • pp.351-357
    • /
    • 2009
  • Phytoestrogens are the natural compounds isolated from plants, which are structurally similar to animal estrogen, $17{\beta}$-estradiol. Tectoridin, a major isoflavone isolated from the rhizome of Belamcanda chinensis. Tectoridin is known as a phytoestrogen, however, the molecular mechanisms underlying its estrogenic effect are remained unclear. In this study we investigated the estrogenic signaling triggered by tectoridin as compared to a famous phytoestrogen, genistein in MCF-7 human breast cancer cells. Tectoridin scarcely binds to ER ${\alpha}$ as compared to $17{\beta}$-estradiol and genistein. Despite poor binding to ER ${\alpha}$, tectoridin induced potent estrogenic effects, namely recovery of the population of cells in the S-phase after serum starvation, transactivation of the estrogen response element, and induction of MCF-7 cell proliferation. The tectoridin-induced estrogenic effect was severely abrogated by treatment with U0126, a specific MEK1/2 inhibitor. Tectoridin promoted phosphorylation of ERK1/2, but did not affect phosphorylation of ER ${\alpha}$ at $Ser^{118}$. It also increased cellular accumulation of cAMP, a hallmark of GPR30-mediated estrogen signaling. These data imply that tectoridin exerts its estrogenic effect mainly via the GPR30 and ERK-mediated rapid nongenomic estrogen signaling pathway. This property of tectoridin sets it aside from genistein where it exerts the estrogenic effects via both an ER-dependent genomic pathway and a GPR30-dependent nongenomic pathway.

Biological Functions and Identification of Novel Biomarker Expressed on the Surface of Breast Cancer-Derived Cancer Stem Cells via Proteomic Analysis

  • Koh, Eun-Young;You, Ji-Eun;Jung, Se-Hwa;Kim, Pyung-Hwan
    • Molecules and Cells
    • /
    • 제43권4호
    • /
    • pp.384-396
    • /
    • 2020
  • Breast cancer is one of the most common life-threatening malignancies and the top cause of cancer deaths in women. Although many conventional therapies exist for its treatment, breast cancer still has many handicaps to overcome. Cancer stem cells (CSCs) are a well-known cause of tumor recurrences due to the ability of CSCs for self-renewal and differentiation into cell subpopulations, similar to stem cells. To fully treat breast cancer, a strategy for the treatment of both cancer cells and CSCs is required. However, current strategies for the eradication of CSCs are non-specific and have low efficacy. Therefore, surface biomarkers to selectively treat CSCs need to be developed. Here, 34 out of 641 surface biomarkers on CSCs were identified by proteomic analysis between the human breast adenocarcinoma cell line MCF-7 and MCF-7-derived CSCs. Among them, carcinoembryonic antigen-related cell adhesion molecules 6 (CEACAM6 or CD66c), a member of the CEA family, was selected as a novel biomarker on the CSC surface. This biomarker was then experimentally validated and evaluated for use as a CSC-specific marker. Its biological effects were assessed by treating breast cancer stem cells (BCSCs) with short hairpin (sh)-RNA under oxidative cellular conditions. This study is the first to evaluate the biological function of CD66c as a novel biomarker on the surface of CSCs. This marker is available as a moiety for use in the development of targeted therapeutic agents against CSCs.

In-Vitro Anticancer and Free Radical Scavenging Potential of Compound Formulation Used in Unani System of Medicine

  • Mannan, Mohd Nazir;Kazmi, Munawwar Husain;Chakraborty, Alokananda;Zakir, Mohammad;Ahmad, Tasleem;Lahari, K.
    • 셀메드
    • /
    • 제10권4호
    • /
    • pp.27.1-27.6
    • /
    • 2020
  • Cancer is one of the leading cause of mortality in India as well as worldwide. The management of cancer by conventional therapy has shown life threatening adverse effects. The researchers are now exploring the natural way of treatment. Unani system of medicine have rich literature for cancer and many compound formulations have been described in this system. Unani system of medicine is based on holistic approach and treat human being as a unit with natural herbs, mineral and animal origin drugs. An important compound Unani formulation (CUF) from the literature has been chosen to explore the Unani claim of its anticancer activity. The phytochemical constituents were assessed using standard phytochemical screening method. Antioxidant property of this formulation was assessed by DPPH assay. The DPPH free radical scavenging assay was carried out by colorimetric method and ascorbic acid was taken as a positive control. Three different extracts of CUF on different concentrations were used to screening on human breast cancer (BCC) MCF-7 cell line. For the estimation of in-vitro cytotoxic potency of the investigated extracts was assessed on MTT assay by using trypan blue method and paclitaxel was used as the standard. Hydro-ethanolic (HE) extract showed highest free radical scavenging activity among all extracts. DPPH Assay showed substantial antioxidant activity of these extracts in hydro-ethanol extract at 1㎍ concentration of CUF. The CUF showed antioxidant and anticancer activity. The claim made by Unani physician has been proved.

적채 분획물의 항균, 암세포 증식 억제효과 (The Effects on Antimicrobial and Cytotoxicity of Brassica oleracea L. Fractions.)

  • 박윤자;전광혜;김선희;배송자
    • 생명과학회지
    • /
    • 제14권4호
    • /
    • pp.567-572
    • /
    • 2004
  • 노화억제, 항균, cholesterol 저하작용 등 다양한 생리활성을 가지고, 기관지염, 천식 등 호흡기 질환에도 옛부터 효과가 있는 것으로 알려져 있으며 식품으로 애용되고 있는 적채를 metanol (BOM)로 먼저 추출하고 이를 hexane 분획물(BOMH), ethyl ether 분획물(BOMEE), ethyl acetate 분획물(BOMEA), butanol 분획물(BOMB) 및 물 분획물(BOMA) 등 다섯가지의 각 용매별로 분획하여 적채의 항균, 암세포 증식 억제 및 QR유도 효과를 연구하였다. 먼저 적채의 각 분획물을 Streptococcus mutans, Bacillus subtilis, Escherichia coli. Pseudomonas aeruginosa 및 Aspergil-lus oryzae의 5가지 균주에 첨가시료농도를 증가시키면서 첨가하였다. 즉, 각 분획 별 시료를 500, 1000, 1500 및 2000 $\mu{g}$/ml의 농도로 사용균주에 각각 처리하였을때 BOMEA에서 비교적 높은 항균 활성 효과를 나타내었고, 그 다음으로는 BOMEE이었다. 적채의 암세포 증식억제 효과(cytotoxicity)를 MTT assay 로 실험한 결과, 3종의 암세포주 HepG2, HeLa 및 MCF-7은 모두 BOMEE에서 높은 암세포 증식억제 효과를 보였으며, HepG2 세포주를 이용한 암예방 QR 유도 활성은 다른 분획층에 비해 비극성 용매층인 BOMH과 BOMEE에서 유의적으로 QR유도 활성을 증가시키는 것으로 나타났다. 이 결과를 기초로 독특한 보라색을 띄며 식탁에서 널리 애용되고 있는 자주색 대표식품인 적채의 항균 및 암세포 성장저지 및 QR 유도 효과를 일으키는 생리활성 물질의 존재와 기전 규명에 유익한 자료가 될 것으로 사료된다.